Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 6-chloro-3,4-dihydro-3-((2-propenylthio)methyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide and (17alpha)-17-hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid monopotassium salt (76270-05-8)

Identification
Name:	Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 6-chloro-3,4-dihydro-3-((2-propenylthio)methyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide and (17alpha)-17-hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid monopotassium salt
Synonyms:	aldatense
CAS:	76270-05-8
Molecular Formula:	C₆₈H₈₅ClKN₅O₁₇S₃
Molecular Weight:	0
InChI:	InChI=1S/C35H42N2O9.C22H30O4.C11H14ClN3O4S3.K/c1-40-21-8-9-22-23-11-12-37-18-20-15-29(46-30(38)10-7-19-13-27(41-2)33(43-4)28(14-19)42-3)34(44-5)31(35(39)45-6)24(20)17-26(37)32(23)36-25(22)16-21;1-20-9-5-15(23)13-14(20)3-4-16-17(20)6-10-21(2)18(16)7-11-22(21,26)12-8-19(24)25;1-2-3-20-6-11-14-8-4-7(12)9(21(13,16)17)5-10(8)22(18,19)15-11;/h7-10,13-14,16,20,24,26,29,31,34,36H,11-12,15,17-18H2,1-6H3;3-4,13,16-18,26H,5-12H2,1-2H3,(H,24,25);2,4-5,11,14-15H,1,3,6H2,(H2,13,16,17);/q;;;+1/p-1/b10-7+;;;/t20-,24+,26-,29-,31+,34+;16?,17?,18?,20-,21-,22+;;/m10../s1
Molecular Structure:
Properties
Safety Data